
    
      The trial will span 2 influenza seasons. Each study year, participants will be randomized to
      receive one dose of either Fluzone® High-Dose or Fluzone® vaccine prior to the start of the
      influenza season and will be followed until the end of each season.

      The duration of each participant's participation in the respective study year will be 6 to 8
      months, depending on the time of enrollment.
    
  